ARCHIVES

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

This article is from The Cancer Letter archive.

Vol. 34 No. 42 | November 14, 2008

Download PDF Visit The Full Archive

Related Articles

Litton’s Government Contracts Status Under Review

September 6, 1985

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

NCI FY 1991 Operating Budget Outlined In Chart

December 7, 1990

NIH To Sponsor Animal Care, Human Protection Workshop

February 21, 1986

Some Children With Hodgkin’s Disease Can Reduce Or Skip Radiation, Study Finds

October 29, 2004

Alternating Mammography, MRI Tested For High-Risk Women

January 30, 2009